Moreover, an increase in some of these pathogenic microbiota may contribute to the low rate of mucosal inflammation through overexpression of proinflammatory cytokines IL-6 and IL-8 as seen in IBS patients [29, 34, 49, 50]. Here, CXCL8 is linked to irritable bowel syndrome.